Search Ontology:
ChEBI

cerivastatin

Term ID
CHEBI:3558
Synonyms
  • (3R,5S,6E)-7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl)-3,5-dihydroxy-6-heptenoic acid
  • (3R,5S,6E)-7-(4-(p-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridyl)-3,5-dihydroxy-6-heptenoic acid
  • (3R,5S,6E)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoic acid
  • (3R,5S,E)-7-(4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyridin-3-yl)-3,5-dihydroxyhept-6-enoic acid
  • Cerivastatin
  • cerivastatin acid
Definition
(3R,5S)-3,5-dihydroxyhept-6-enoic acid in which the (7E)-hydrogen is substituted by a 4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyridin-3-yl group. Formerly used (as its sodium salt) to lower cholesterol and prevent cardiovascular disease, it was withdrawn from the market worldwide in 2001 following reports of a severe form of muscle toxicity.
References
  • beilstein:8366578
  • cas:145599-86-6
  • drugbank:DB00439
  • drugcentral:577
  • kegg.compound:C07966
  • kegg.drug:D07661
  • pubmed:17560788
  • pubmed:18155906
  • wikipedia.en:Cerivastatin
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from cerivastatin
Phenotype where environments contain cerivastatin
Phenotype modified by environments containing cerivastatin
Phenotype affecting cerivastatin
Human Disease Model